These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 8044987
1. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine. Pérez-Bendito D, Gómez-Hens A, Gaikwad A. Clin Chem; 1994 Aug; 40(8):1489-93. PubMed ID: 8044987 [Abstract] [Full Text] [Related]
2. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS. Ros JJ, Pelders MG, Egberts AC. J Anal Toxicol; 1998 Aug; 22(1):40-4. PubMed ID: 9491967 [Abstract] [Full Text] [Related]
3. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. Fraser AD, Worth D. Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292 [Abstract] [Full Text] [Related]
4. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine. Wennig R, Moeller MR, Haguenoer JM, Marocchi A, Zoppi F, Smith BL, de la Torre R, Carstensen CA, Goerlach-Graw A, Schaeffler J, Leinberger R. J Anal Toxicol; 1998 Dec; 22(2):148-55. PubMed ID: 9547412 [Abstract] [Full Text] [Related]
5. Interpretations of the TDxFLx calibration data of the abused drugs. Sihn YS, Chung HS. Forensic Sci Int; 2003 Jan 09; 131(1):1-7. PubMed ID: 12505464 [Abstract] [Full Text] [Related]
6. Interference of common household chemicals in immunoassay methods for drugs of abuse. Warner A. Clin Chem; 1989 Apr 09; 35(4):648-51. PubMed ID: 2539273 [Abstract] [Full Text] [Related]
7. Analytic performance of immunoassays for drugs of abuse below established cutoff values. Luzzi VI, Saunders AN, Koenig JW, Turk J, Lo SF, Garg UC, Dietzen DJ. Clin Chem; 2004 Apr 09; 50(4):717-22. PubMed ID: 14764642 [Abstract] [Full Text] [Related]
8. Papain: a novel urine adulterant. Burrows DL, Nicolaides A, Rice PJ, Dufforc M, Johnson DA, Ferslew KE. J Anal Toxicol; 2005 Apr 09; 29(5):275-95. PubMed ID: 16105251 [Abstract] [Full Text] [Related]
9. Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines. Agius R, Nadulski T, Kahl HG, Dufaux B. Drug Test Anal; 2013 Jun 09; 5(6):390-9. PubMed ID: 23349145 [Abstract] [Full Text] [Related]
10. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. Schwarzhoff R, Cody JT. J Anal Toxicol; 1993 Jun 09; 17(1):14-7. PubMed ID: 8429620 [Abstract] [Full Text] [Related]
11. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study. Bogusz M, Aderjan R, Schmitt G, Nadler E, Neureither B. Forensic Sci Int; 1990 Nov 09; 48(1):27-37. PubMed ID: 2279719 [Abstract] [Full Text] [Related]
12. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry. Tsai SC, ElSohly MA, Dubrovsky T, Twarowska B, Towt J, Salamone SJ. J Anal Toxicol; 1998 Oct 09; 22(6):474-80. PubMed ID: 9788522 [Abstract] [Full Text] [Related]
13. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay. ElSohly MA, Jones AB, ElSohly HN. J Anal Toxicol; 1990 Oct 09; 14(5):277-9. PubMed ID: 2175818 [Abstract] [Full Text] [Related]
14. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard. Abou El Hassan M, Colantonio D, Likhodii S, Nassar BA. Clin Biochem; 2021 Jul 09; 93():99-103. PubMed ID: 33844982 [Abstract] [Full Text] [Related]
15. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops. Pearson SD, Ash KO, Urry FM. Clin Chem; 1989 Apr 09; 35(4):636-8. PubMed ID: 2467764 [Abstract] [Full Text] [Related]
16. Fluorescence polarization immunoassay for the detection of drugs of abuse in human whole blood. Keller T, Schneider A, Dirnhofer R, Jungo R, Meyer W. Med Sci Law; 2000 Jul 09; 40(3):258-62. PubMed ID: 10976190 [Abstract] [Full Text] [Related]